Prenetics Global Limited Overview
Pro stress-test →Prenetics Global Limited is a health sciences company headquartered in Hong Kong with a presence in the United States, focusing on early detection, prevention, and treatment of diseases, particularly cancer. The company operates IM8, a premium health and longevity brand co-founded with David Beckham that became the fastest-growing supplement brand globally, reaching $100 million in annual recurring revenue within 11 months of launch.
Strategic Profile
Pro stress-test →Prenetics operates through two main segments: a Diagnostics segment focused on precision oncology testing services, and a Prevention segment engaged in genetics testing and stool-based DNA tests for early colorectal cancer screening. The company has diversified its revenue streams beyond traditional diagnostics through high-growth consumer health brands while maintaining its core cancer-focused diagnostic capabilities.
Competitive Landscape
Pro stress-test →Prenetics competes in two distinct markets. In consumer supplements, it faces competition from established brands like GNC, Herbalife, and emerging DTC wellness companies. In genetic testing and cancer diagnostics, key competitors include Invitae, Myriad Genetics, Guardant Health, and Foundation Medicine. IM8's rapid growth and celebrity backing differentiate it in a crowded supplement space, while its precision oncology platform addresses underserved needs in early cancer detection.
Industry Context
Prenetics Global Limited operates in Health Sciences & Diagnostics.
Key facts
Founded: 2014 · Headquarters: Hong Kong, United States · Revenue: $36M (Q1 2026 preliminary)